Key facts
- Notable investors include Global Brain, Shizuoka Capital, Nippon Venture Capital, FFG Venture Business Partners, ARKRAY & PARTNERS — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for 12 Pharmacy
- ·The full record, as it builds
Funding rounds
No funding rounds for 12 Pharmacy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 12 Pharmacy
Operator of a veterinary pharmacy service intended to offer medication delivery for animal hospitals. The company specializes in outsourcing dispensing operations, addressing long wait times for medication, staff shortages, and medication inventory management, enabling clients to reduce wait times and manage dispensing processes outside veterinary clinics.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Tokyo, Japan
- Founded
- 2023
- Employees
- 50
- Website
- 12pharmacy.co.jp/
- Ownership
- Privately Held (backing)
12 Pharmacy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 12 Pharmacy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 12 Pharmacy in its N-PORT filings yet. We sweep new filings monthly.